Sign up for a free trial and join thousands of other leading professionals. Click here to start!

Bleeding Disorders (incl. Hemophilia, Von Willebrand Disease) News

Home | Index > Health > Heart & Blood > Bleeding Disorders (incl. Hemophilia, Von Willebrand Disease)

TAKE THIS POLL
Does John McCain's military service experience give him a substantial advantage over Barack Obama? (Jul. 3, 2008) Yes, such experience is very important for the U.S. president. No. Don't know.

Missouri data mirrors national trend for HIV/AIDS diagnoses in some categories 5 Jul 2008 23:14 GMT
... The report noted that it looked at people who ... young people, because they likely contracted the disease recently. Missouri data mirrors the national data. ... care providers. White was a teenager with hemophilia who was diagnosed with AIDS in 1984. ...
Battlefield medicine: Waging war on death 5 Jul 2008 17:14 GMT
... CORPORAL JON BEVAN RLC, GETTY IMAGES FILE PHOTO Medics ... patients or potentially infect them with harmful diseases. But surgeons in Iraq and Afghanistan began ... and the United States for use on hemophiliacs. U. S. regulators have warned it could ...
Waging war on death 5 Jul 2008 15:35 GMT
... CORPORAL JON BEVAN RLC, GETTY IMAGES FILE PHOTO Medics ... patients or potentially infect them with harmful diseases. But surgeons in Iraq and Afghanistan began ... and the United States for use on hemophiliacs. U. S. regulators have warned it could ...
JAPAN: Government Names 1,825 Hospitals on Tainted Coagulant Fears 5 Jul 2008 04:31 GMT
... JAPAN: Government Names 1,825 Hospitals on Tainted Coagulant Fears ... were used on patients who were not hemophiliacs. The products were routinely used in during ... media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. ...
Clinical trial update 4 Jul 2008 14:58 GMT
... Medgenics, Inc. is a clinical-stage biopharmaceutical company developing ... the treatment of a range of chronic diseases. Medgenics currently has two products in development based ... Other potential areas include multiple sclerosis (interferon-β), haemophilia (Factor XIII), paediatric growth hormone deficiency (human ...

Deals Roundup Maxygen Partners Hemophilia Drug in Potential $120M Deal. 4 Jul 2008 11:59 GMT
... Deals Roundup Maxygen Partners Hemophilia Drug in Potential $120M Deal. Maxygen Inc. landed a big pharma partner for its early ...
First guideline released for von Willebrand Disease 3 Jul 2008 20:35 GMT
... #imenus10 .imeam span,#imenus10 .imeamj span height:0px;left:0px; left;} #imenus10 ul .imeas span,#imenus10 ul .imeasj span height:0px;left:0px;top:0px; left;} ...
Maxygen To Sell Hemophilia Treatment Program To Bayer Unit For $90 Million 3 Jul 2008 18:31 GMT
... (financialwire.net via COMTEX) -- July 3, 2008 (FinancialWire) ... (NASDAQ: MAXY) has agreed to sell its hemophilia treatment program to Bayer's health care division for ...
Wyeth and Progenics Receive Approval from European Commission for RELISTOR for Opioid-Induced Constipation in Advanced 3 Jul 2008 17:59 GMT
... - Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), and ... such as incurable cancer and other end-stage diseases. Similar figures are not available for Europe ... gastrointestinal health, central nervous system, inflammation, transplantation, hemophilia, oncology, vaccines and nutritional products. Wyeth is ...
Wyeth and Progenics Receive Approval from European Commission for RELISTOR for Opioid-Induced Constipation in Advanced Illness Patients 3 Jul 2008 17:05 GMT
... , today announced that the companies have received marketing approval ... such as incurable cancer and other end-stage diseases. Similar figures are not available for Europe ... gastrointestinal health, central nervous system, inflammation, transplantation, hemophilia, oncology, vaccines and nutritional products. Wyeth is ...

Not satisfied with this news section? Make your own with the Newsletter Manager or try our other media monitoring services.

Bayer Acquires Maxygen's Hemophilia Program 3 Jul 2008 14:37 GMT
... Posted on July 3, 2008 @ 08:38 am ’s hemophilia program assets, including next-generation recombinant Factor VIIa protein MAXY-VII, the company's lead candidate, which is ...
Firms see unusual price changes 3 Jul 2008 11:36 GMT
... Last updated: Thursday July 3, 2008, EDT 6:18 AM ... largest drugmaker, bought the U.S. biopharmaceutical company's hemophilia-drug research assets for as much as $120 ... 2005. The maker of drugs for infectious diseases said it will sell 30.3 million shares ...
OTCPicks.com: OTCPicks.com Stocks to Watch for Thursday, July 3rd SNRS, UVSE, AWSR, HTOG, MAXY 3 Jul 2008 09:17 GMT
... Jul 03, 2008 (M2 PRESSWIRE via COMTEX) -- Our Stocks ... commercialization of protein pharmaceuticals for treatment of disease and serious medical conditions in the United ... in pre-clinical stage for the treatment of hemophilia and acute bleeding conditions; and MAXY-4, a ...
Liquid of life 3 Jul 2008 05:52 GMT
... A blood transfusion is the pouring of blood into the ... normally when it needs to. People with haemophilia have a lack of factor eight. Many ... died young as a result of this disease. Boys are mainly affected by this condition because ...
Platelets in Hematologic and Cardiovascular Disorders: A Clinical Handbook 3 Jul 2008 04:31 GMT
... the 19th century. Once a special interest of hematologists who investigated the mechanisms of bleeding disorders, platelets now command the oncologists, as well as pharmaceutical and instrumentation companies. The relatively ...
1,825 hospitals named in blood use 3 Jul 2008 03:18 GMT
... The health ministry Tuesday made public the names of ... B or C on patients other than hemophiliacs. The institutions had bought at least one ...
Bayer acquires Maxygen's hemophilia program assets 3 Jul 2008 02:55 GMT
... The therapeutic candidate is expected to enter Phase I ... expected to further Bayer's leadership position in hemophilia care where it offers the recombinant Factor VIII ...
Bayer Buys Maxygen Hematology Drugs 3 Jul 2008 02:17 GMT
... July 3, 2008 | Vol. 7 No. 130 Bayer is acquiring Maxygen’s hemophilia program, including a next-generation recombinant Factor VIIa protein, for $90 million upfront and a final ...
Maxygen Partners Hemophilia Drug in Potential $120M Deal 3 Jul 2008 00:53 GMT
... ...
Hemophiliacs suffer for lack of treatment 3 Jul 2008 00:52 GMT
... Hemophiliacs in Guangdong suffer for lack of treatment ... pharmaceutical market of effective medication for the disease. Hemophilia is a genetic disorder characterized by ...

THESE STORIES ARE NOT PUBLISHED BY IPD GROUP, INC. AND THESE LINKS WILL TAKE YOU TO OTHER WEBSITES. SOME OF THESE WEBSITES REQUIRE THEIR OWN REGISTRATION TO READ THEIR STORIES. PLEASE READ THE DISCLAIMER FOR MORE DETAILS. >>>

Hemophiliacs in Guangdong suffer for lack of treatment 3 Jul 2008 00:52 GMT
... Hemophiliacs in Guangdong suffer for lack of treatment ... pharmaceutical market of effective medication for the disease. Hemophilia is a genetic disorder characterized by ...
OTCPicks.com: OTCPicks.com Daily Market Movers Digest Midday Report for Wednesday, July 2nd LLSR, WNEA, ETFC, HTOG, MAXY 2 Jul 2008 21:31 GMT
... Jul 02, 2008 (M2 PRESSWIRE via COMTEX) -- Our Stocks ... commercialization of protein pharmaceuticals for treatment of disease and serious medical conditions in the United ... in pre-clinical stage for the treatment of hemophilia and acute bleeding conditions; and MAXY-4, a ...
GTC Biotherapeutics Receives Notice Related to Nasdaq Minimum Market Value Rule 2 Jul 2008 20:30 GMT
... ) has received a Staff Deficiency Letter from The Nasdaq ... which are used for the treatment of hemophilia, and alpha-1 antitrypsin. GTC also has a ...
Wireless Technology Supports Patient eDiary Service 2 Jul 2008 19:30 GMT
... Jasper Wireless says that it has enabled Arrowhead Electronic ... new long-acting clotting factor used to treat hemophilia. The innovative eDiary combines an easy-to-use handheld ...
Bayer HealthCare Acquires Maxygen's Hemophilia Program 2 Jul 2008 19:30 GMT
... Drug Discovery & Development - July 02, 2008 Bayer ... Bayer HealthCare is expanding its commitment to hemophilia with the acquisition of Maxygen’s hemophilia program assets, ...